featured
VHL Substrate Transcription Factor ZHX2 Is an Oncogenic Driver in ccRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Science (New York, N.Y.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
VHL Substrate Transcription Factor ZHX2 as an Oncogenic Driver in Clear Cell Renal Cell Carcinoma
Science 2018 Jul 20;361(6399)290-295, J Zhang, T Wu, J Simon, M Takada, R Saito, C Fan, XD Liu, E Jonasch, L Xie, X Chen, X Yao, BT Teh, P Tan, X Zheng, M Li, C Lawrence, J Fan, J Geng, X Liu, L Hu, J Wang, C Liao, K Hong, G Zurlo, JS Parker, JT Auman, CM Perou, WK Rathmell, WY Kim, MW Kirschner, WG Kaelin, AS Baldwin, Q ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.